Piedmont Investment Advisors Has Cut Abbvie Com (ABBV) Position by $2.01 Million; Share Value Declined; Lauder Estee Cos (EL) Shareholder Martin Currie LTD Cut Position by $2.27 Million

May 18, 2018 - By Michael Collier

AbbVie Inc. (NYSE:ABBV) Logo

Piedmont Investment Advisors Llc decreased its stake in Abbvie Inc Com (ABBV) by 5.44% based on its latest 2017Q4 regulatory filing with the SEC. Piedmont Investment Advisors Llc sold 20,944 shares as the company’s stock declined 6.31% with the market. The institutional investor held 364,039 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $35.21 million, down from 384,983 at the end of the previous reported quarter. Piedmont Investment Advisors Llc who had been investing in Abbvie Inc Com for a number of months, seems to be less bullish one the $167.13B market cap company. The stock increased 0.27% or $0.28 during the last trading session, reaching $105.32. About 6.70 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 39.20% since May 18, 2017 and is uptrending. It has outperformed by 27.65% the S&P500.

Martin Currie Ltd decreased its stake in Lauder Estee Cos Inc (EL) by 30.88% based on its latest 2017Q4 regulatory filing with the SEC. Martin Currie Ltd sold 17,903 shares as the company’s stock rose 14.83% while stock markets declined. The institutional investor held 40,082 shares of the consumer non-durables company at the end of 2017Q4, valued at $5.10 million, down from 57,985 at the end of the previous reported quarter. Martin Currie Ltd who had been investing in Lauder Estee Cos Inc for a number of months, seems to be less bullish one the $53.18B market cap company. The stock increased 0.14% or $0.2 during the last trading session, reaching $144.9. About 2.48M shares traded or 26.38% up from the average. The Estée Lauder Companies Inc. (NYSE:EL) has risen 70.93% since May 18, 2017 and is uptrending. It has outperformed by 59.38% the S&P500.

Martin Currie Ltd, which manages about $1.42B US Long portfolio, upped its stake in Philip Morris Intl Inc (NYSE:PM) by 38,664 shares to 248,764 shares, valued at $26.28 million in 2017Q4, according to the filing. It also increased its holding in Canadian Natl Ry Co (NYSE:CNI) by 29,284 shares in the quarter, for a total of 115,384 shares, and has risen its stake in Ishares Tr (INDA).

Analysts await The Estée Lauder Companies Inc. (NYSE:EL) to report earnings on August, 17. They expect $0.56 earnings per share, up 9.80% or $0.05 from last year’s $0.51 per share. EL’s profit will be $205.54M for 64.69 P/E if the $0.56 EPS becomes a reality. After $1.17 actual earnings per share reported by The Estée Lauder Companies Inc. for the previous quarter, Wall Street now forecasts -52.14% negative EPS growth.

Since February 5, 2018, it had 0 insider buys, and 10 selling transactions for $37.14 million activity. The insider Polcer Gregory sold $6.12M. Freda Fabrizio sold $7.69M worth of The Estée Lauder Companies Inc. (NYSE:EL) on Friday, February 16. The insider LAUDER RONALD S FOUNDATION sold $2.27 million. Another trade for 13,050 shares valued at $1.80M was sold by Haney Carl P.. 26,203 The Estée Lauder Companies Inc. (NYSE:EL) shares with value of $3.50 million were sold by O’HARE MICHAEL. Another trade for 5,000 shares valued at $685,100 was made by TRAVIS TRACEY THOMAS on Tuesday, February 13.

More recent The Estée Lauder Companies Inc. (NYSE:EL) news were published by: Streetinsider.com which released: “Estee Lauder (EL) Estimates, PT Raised at Morgan Stanley as Channel Mix Tipping Point Has Been Reached” on May 15, 2018. Also Benzinga.com published the news titled: “Barclays Finds Coca-Cola’s Stock Refreshing As Consumer Staples Industry Suffers” on May 17, 2018. Seekingalpha.com‘s news article titled: “Coty – Smells Bad” with publication date: May 13, 2018 was also an interesting one.

Investors sentiment increased to 1.2 in Q4 2017. Its up 0.17, from 1.03 in 2017Q3. It improved, as 41 investors sold EL shares while 224 reduced holdings. 112 funds opened positions while 206 raised stakes. 188.03 million shares or 1.16% less from 190.23 million shares in 2017Q3 were reported. 1St Source National Bank & Trust invested in 15,492 shares or 0.16% of the stock. Kentucky Retirement Insur Trust Fund reported 0.13% of its portfolio in The Estée Lauder Companies Inc. (NYSE:EL). Apg Asset Nv holds 1.43 million shares. Pub Sector Pension Investment Board has 11,939 shares. Massmutual Tru Co Fsb Adv accumulated 0.04% or 9,066 shares. Waddell And Reed Fincl, a Kansas-based fund reported 72,529 shares. Laffer Invests holds 0.74% or 23,255 shares in its portfolio. Bath Savings Tru stated it has 28,755 shares. Chesley Taft And Assocs Lc reported 3,835 shares or 0.04% of all its holdings. 2,351 are held by Brown Advisory Ltd. Mitsubishi Ufj Trust & Banking Corp holds 0.18% or 827,768 shares in its portfolio. Balyasny Asset Mgmt Llc stated it has 12,289 shares. Nomura Asset Mgmt Communication Ltd holds 52,957 shares. Mark Sheptoff Fincl Planning Lc holds 0.2% or 2,380 shares. Sirios Cap Mngmt Lp invested 1.21% in The Estée Lauder Companies Inc. (NYSE:EL).

Among 32 analysts covering Estee Lauder (NYSE:EL), 24 have Buy rating, 1 Sell and 7 Hold. Therefore 75% are positive. Estee Lauder had 114 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Buy” rating by Stifel Nicolaus on Tuesday, April 17. The stock of The Estée Lauder Companies Inc. (NYSE:EL) earned “Overweight” rating by Atlantic Securities on Thursday, February 11. The firm earned “Buy” rating on Friday, August 18 by Stifel Nicolaus. The firm earned “Buy” rating on Friday, August 18 by Piper Jaffray. As per Thursday, July 6, the company rating was maintained by Stifel Nicolaus. The stock of The Estée Lauder Companies Inc. (NYSE:EL) has “Buy” rating given on Tuesday, August 8 by RBC Capital Markets. Jefferies maintained the stock with “Buy” rating in Wednesday, January 17 report. As per Thursday, January 4, the company rating was maintained by Wells Fargo. Jefferies maintained the shares of EL in report on Monday, August 7 with “Buy” rating. As per Thursday, November 3, the company rating was downgraded by CSLA.

Piedmont Investment Advisors Llc, which manages about $2.73 billion and $4.97B US Long portfolio, upped its stake in Broadcom Ltd Shs by 5,066 shares to 95,140 shares, valued at $24.44M in 2017Q4, according to the filing. It also increased its holding in Valero Energy Corp New Com (NYSE:VLO) by 3,969 shares in the quarter, for a total of 198,063 shares, and has risen its stake in Biogen Inc Com (NASDAQ:BIIB).

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.05, from 0.85 in 2017Q3. It dived, as 42 investors sold ABBV shares while 695 reduced holdings. 139 funds opened positions while 448 raised stakes. 1.06 billion shares or 0.35% more from 1.06 billion shares in 2017Q3 were reported. Bangor Bankshares invested in 6,691 shares. First Bancorp Of Hutchinson, Kansas-based fund reported 3,230 shares. Conestoga Cap Advsr Limited Liability Company holds 0.03% or 7,935 shares in its portfolio. Connecticut-based Timber Hill Ltd Limited Liability Company has invested 0.13% in AbbVie Inc. (NYSE:ABBV). Winslow Capital Management Ltd Limited Liability Company owns 6 shares. Dowling & Yahnke Limited Liability Co has 75,657 shares. Navellier & Assoc reported 28,439 shares. Partnervest Advisory Services Lc has invested 0.37% in AbbVie Inc. (NYSE:ABBV). Sigma Planning Corporation owns 56,438 shares or 0.42% of their US portfolio. Old Bancorp In invested in 1.32% or 263,433 shares. Callahan Advsr Lc accumulated 11,649 shares. Captrust Financial Advisors reported 0.54% stake. Greatmark Investment invested 1.13% of its portfolio in AbbVie Inc. (NYSE:ABBV). Puzo Michael J owns 19,126 shares. 3,527 were reported by Iron Ltd Co.

Since December 14, 2017, it had 0 insider buys, and 11 selling transactions for $47.70 million activity. SEVERINO MICHAEL had sold 2,643 shares worth $311,684. 1,337 shares were sold by SALEKI-GERHARDT AZITA, worth $157,458 on Wednesday, February 28. Another trade for 18,129 shares valued at $2.15 million was made by RICHMOND TIMOTHY J. on Wednesday, February 28. Michael Robert A. had sold 4,294 shares worth $512,853. Schumacher Laura J had sold 25,000 shares worth $2.95 million. 83,574 shares valued at $9.57M were sold by ALBAN CARLOS on Wednesday, February 28.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Streetinsider.com which released: “AbbVie (ABBV) to Show Progress and Growth in Oncology Research at ASCO” on May 16, 2018, also Seekingalpha.com with their article: “AbbVie: Can Mylan Pull Off A Humira Biosimilar?” published on May 01, 2018, Seekingalpha.com published: “AbbVie’s upadacitinib successful in Japan-based RA study” on April 25, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Streetinsider.com and their article: “AbbVie (ABBV) option implied volatility, to present investigational oncology portfolio at ASCO” published on May 17, 2018 as well as Seekingalpha.com‘s news article titled: “Key events next week – healthcare” with publication date: April 20, 2018.

Among 23 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 11 Hold. Therefore 43% are positive. Abbvie Inc had 91 analyst reports since July 21, 2015 according to SRatingsIntel. Atlantic Securities initiated the stock with “Neutral” rating in Friday, December 18 report. The company was maintained on Friday, July 14 by Jefferies. The firm has “Sell” rating by Societe Generale given on Wednesday, April 6. The stock has “Equal-Weight” rating by Morgan Stanley on Monday, April 30. The rating was upgraded by Morgan Stanley to “Overweight” on Monday, November 2. As per Friday, October 23, the company rating was maintained by UBS. The stock of AbbVie Inc. (NYSE:ABBV) has “” rating given on Monday, September 28 by Citigroup. SunTrust maintained it with “Buy” rating and $15700 target in Thursday, March 22 report. Morgan Stanley maintained the stock with “Equal-Weight” rating in Tuesday, January 30 report. The company was initiated on Friday, September 2 by Raymond James.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on July, 27. They expect $1.97 earnings per share, up 38.73% or $0.55 from last year’s $1.42 per share. ABBV’s profit will be $3.13 billion for 13.37 P/E if the $1.97 EPS becomes a reality. After $1.87 actual earnings per share reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 5.35% EPS growth.

The Estée Lauder Companies Inc. (NYSE:EL) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>